Clinical Trials
3 trialsNCT02812992 2021-08-10
GrantPax
AIO-Studien-gGmbH
Phase 4 Completed
NCT02316327 2016-10-05
Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab
Fundacion Clinic per a la Recerca Biomédica
Phase 4 Completed
NCT02000531 2016-01-13
Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population
Hoffmann-La Roche
Phase 4 Completed